Kimia Biosciences Limited (BOM:530313)
India flag India · Delayed Price · Currency is INR
33.56
+0.08 (0.24%)
At close: Nov 17, 2026

Kimia Biosciences Balance Sheet

Millions INR. Fiscal year is Apr - Mar.

Assets

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Equivalents
7.753.162.061.481.782.05
Trading Asset Securities
----0.630.6
Cash & Short-Term Investments
7.753.162.061.482.412.65
Cash Growth
9.02%53.23%39.63%-38.73%-9.20%-58.87%
Accounts Receivable
228.31293.2367.51275.54305.9302.01
Other Receivables
-3.167.55.365.7836.69
Receivables
228.31296.36375.01280.9311.67338.7
Inventory
350.59262.58345.83308.04482.34370.18
Prepaid Expenses
-3.792.151.321.423.15
Other Current Assets
96.6170.3227.8722.3529.6316.01
Total Current Assets
683.27636.2752.92614.08827.47730.7
Property, Plant & Equipment
290.67303.96309.02323.8341.53350.82
Other Intangible Assets
79.244.760.220.410.851.45
Long-Term Deferred Tax Assets
4.856.2817.6357.8439.699.08
Long-Term Deferred Charges
-66.2323.56---
Other Long-Term Assets
17.2714.548.773.543.642.86
Total Assets
1,0751,0321,112999.671,2131,095

Liabilities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Accounts Payable
300.84422.15504.89399.88465.86402.06
Accrued Expenses
-38.651.6157.5550.9329.71
Short-Term Debt
223.1287.1196.38197.91198.32148.1
Current Portion of Long-Term Debt
-31.0925.5822.0122.5213.6
Current Portion of Leases
0.831.081.861.21--
Current Unearned Revenue
-31.8237.9315.0322.9716.99
Other Current Liabilities
50.740.0100.793.387.56
Total Current Liabilities
575.53611.84818.25694.38763.98618.02
Long-Term Debt
276.7228.09167272.17361.63293.33
Long-Term Leases
0.490.492.761.85--
Long-Term Unearned Revenue
--8.4813.4818.4823.47
Pension & Post-Retirement Benefits
-12.1514.1512.6812.5311.21
Other Long-Term Liabilities
17.932.21.811.811.92-
Total Liabilities
870.65854.771,012996.361,159946.03

Shareholders' Equity

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Common Stock
47.3147.3147.3147.3147.3147.31
Additional Paid-In Capital
-60.8560.8560.8560.8560.85
Retained Earnings
-69.04-8.5-104.86-53.5440.72
Comprehensive Income & Other
157.33-----
Total Common Equity
204.64177.2199.663.3154.63148.88
Shareholders' Equity
204.64177.2199.663.3154.63148.88
Total Liabilities & Equity
1,0751,0321,112999.671,2131,095

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Total Debt
501.14347.85393.58495.14582.47455.03
Net Cash (Debt)
-493.4-344.7-391.52-493.67-580.06-452.38
Net Cash Growth
------
Net Cash Per Share
-10.46-7.29-8.28-10.43-12.26-9.56
Filing Date Shares Outstanding
47.7547.3147.3147.3147.3147.31
Total Common Shares Outstanding
47.7547.3147.3147.3147.3147.31
Working Capital
107.7424.37-65.33-80.363.49112.68
Book Value Per Share
4.293.752.110.071.153.15
Tangible Book Value
125.4172.4499.442.953.78147.44
Tangible Book Value Per Share
2.633.642.100.061.143.12
Land
-4.754.754.754.754.75
Buildings
-61.1761.1761.176060
Machinery
-451.84423.41401.66390.95373.58
Construction In Progress
-1.690.035.766.06-